Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes

Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes : a case report. / Dirksen, Carsten; Jacobsen, Siv H; Bojsen-Møller, Kirstine N; Jørgensen, Nils B; Naver, Lars S; Hvolris, Lisbeth E; Worm, Dorte; Madsbad, Sten; Holst, Jens Juul; Hansen, Dorte L.

I: Obesity Research & Clinical Practice, Bind 7, Nr. 4, 07.12.2013, s. e269-74.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Dirksen, C, Jacobsen, SH, Bojsen-Møller, KN, Jørgensen, NB, Naver, LS, Hvolris, LE, Worm, D, Madsbad, S, Holst, JJ & Hansen, DL 2013, 'Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report', Obesity Research & Clinical Practice, bind 7, nr. 4, s. e269-74. https://doi.org/10.1016/j.orcp.2012.01.002

APA

Dirksen, C., Jacobsen, S. H., Bojsen-Møller, K. N., Jørgensen, N. B., Naver, L. S., Hvolris, L. E., Worm, D., Madsbad, S., Holst, J. J., & Hansen, D. L. (2013). Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report. Obesity Research & Clinical Practice, 7(4), e269-74. https://doi.org/10.1016/j.orcp.2012.01.002

Vancouver

Dirksen C, Jacobsen SH, Bojsen-Møller KN, Jørgensen NB, Naver LS, Hvolris LE o.a. Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report. Obesity Research & Clinical Practice. 2013 dec. 7;7(4):e269-74. https://doi.org/10.1016/j.orcp.2012.01.002

Author

Dirksen, Carsten ; Jacobsen, Siv H ; Bojsen-Møller, Kirstine N ; Jørgensen, Nils B ; Naver, Lars S ; Hvolris, Lisbeth E ; Worm, Dorte ; Madsbad, Sten ; Holst, Jens Juul ; Hansen, Dorte L. / Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes : a case report. I: Obesity Research & Clinical Practice. 2013 ; Bind 7, Nr. 4. s. e269-74.

Bibtex

@article{135919bb1bb548e5841824f6c1cea541,

title = "Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report",

abstract = "Experience with Roux-en-Y gastric bypass in patients with type 1 diabetes is very limited, despite an increasing prevalence of obesity also in this population. We describe changes in anthropometric measures, insulin dose, HbA1c, blood pressure, lipid status, and metabolic response to a liquid mixed meal throughout the first year after RYGB in an obese patient with type 1 diabetes. No change in HbA1c was observed, but a 48% reduction in weight-adjusted insulin dose and improvements in cardiovascular risk factors was seen 1 year after surgery. Exaggerated secretions of anorexigenic gut hormones were seen during the meals.",

author = "Carsten Dirksen and Jacobsen, {Siv H} and Bojsen-M{\o}ller, {Kirstine N} and J{\o}rgensen, {Nils B} and Naver, {Lars S} and Hvolris, {Lisbeth E} and Dorte Worm and Sten Madsbad and Holst, {Jens Juul} and Hansen, {Dorte L}",

year = "2013",

month = dec,

day = "7",

doi = "10.1016/j.orcp.2012.01.002",

language = "English",

volume = "7",

pages = "e269--74",

journal = "Obesity Research and Clinical Practice",

issn = "1871-403X",

publisher = "Elsevier",

number = "4",

}

RIS

TY - JOUR

T1 - Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes

T2 - a case report

AU - Dirksen, Carsten

AU - Jacobsen, Siv H

AU - Bojsen-Møller, Kirstine N

AU - Jørgensen, Nils B

AU - Naver, Lars S

AU - Hvolris, Lisbeth E

AU - Worm, Dorte

AU - Madsbad, Sten

AU - Holst, Jens Juul

AU - Hansen, Dorte L

PY - 2013/12/7

Y1 - 2013/12/7

N2 - Experience with Roux-en-Y gastric bypass in patients with type 1 diabetes is very limited, despite an increasing prevalence of obesity also in this population. We describe changes in anthropometric measures, insulin dose, HbA1c, blood pressure, lipid status, and metabolic response to a liquid mixed meal throughout the first year after RYGB in an obese patient with type 1 diabetes. No change in HbA1c was observed, but a 48% reduction in weight-adjusted insulin dose and improvements in cardiovascular risk factors was seen 1 year after surgery. Exaggerated secretions of anorexigenic gut hormones were seen during the meals.

AB - Experience with Roux-en-Y gastric bypass in patients with type 1 diabetes is very limited, despite an increasing prevalence of obesity also in this population. We describe changes in anthropometric measures, insulin dose, HbA1c, blood pressure, lipid status, and metabolic response to a liquid mixed meal throughout the first year after RYGB in an obese patient with type 1 diabetes. No change in HbA1c was observed, but a 48% reduction in weight-adjusted insulin dose and improvements in cardiovascular risk factors was seen 1 year after surgery. Exaggerated secretions of anorexigenic gut hormones were seen during the meals.

U2 - 10.1016/j.orcp.2012.01.002

DO - 10.1016/j.orcp.2012.01.002

M3 - Journal article

C2 - 24306154

VL - 7

SP - e269-74

JO - Obesity Research and Clinical Practice

JF - Obesity Research and Clinical Practice

SN - 1871-403X

IS - 4

ER -

ID: 117852898

Biomedicinsk Institut